1 INTRODUCTION 14
1.1 OBJECTIVES OF STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.2 SECONDARY RESEARCH 18
2.2.1 KEY DATA FROM SECONDARY SOURCES 18
2.3 PRIMARY RESEARCH 19
2.3.1 KEY DATA FROM PRIMARY SOURCES 20
2.3.2 KEY INSIGHTS FROM PRIMARY SOURCES 22
2.3.3 KEY INDUSTRY INSIGHTS 23
2.4 MARKET SIZE ESTIMATION METHODOLOGY 23
2.5 DATA VALIDATION & TRIANGULATION 27
2.6 ASSUMPTIONS FOR THE STUDY 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 34
4.1 PATIENT ENGAGEMENT SOLUTIONS: MARKET SNAPSHOT 34
4.2 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY REGION AND END USER 35
4.3 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY THERAPEUTIC AREA
(2017 VS. 2022) 36
4.4 GEOGRAPHICAL SNAPSHOT: PATIENT ENGAGEMENT SOLUTIONS MARKET 37

5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care 39
5.2.1.2 Implementation of incentives to shift the burden of risk from healthcare payers to providers 40
5.2.1.3 Growing popularity of patient engagement solutions among the aging population 40
5.2.1.4 Significant investments in HCIT by stakeholders 41
5.2.1.5 Rising number of collaborations and partnerships between stakeholders 41
5.2.1.6 Increasing utilization of mobile health solutions 42
5.2.2 RESTRAINTS 43
5.2.2.1 Requirement of investments in infrastructure for implementing patient engagement solutions 43
5.2.2.2 Protection of patient information 43
5.2.2.3 Lack of interoperability 43
5.2.2.4 Dearth of skilled IT professionals in the healthcare industry 44
5.2.3 OPPORTUNITIES 44
5.2.3.1 Emerging asian countries 44
5.2.3.2 Growing medical tourism 45
5.2.3.3 Wearable health technology 45
5.2.3.4 Cloud-based models 45
5.2.4 CHALLENGES 46
5.2.4.1 High cost of deployment 46
5.2.4.2 Lack of health literacy 46
5.3 PATIENT ENGAGEMENT SOLUTIONS MARKET, PRICING ANALYSIS 47

6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT 49
6.1 INTRODUCTION 50
6.2 HARDWARE 50
6.3 SOFTWARE 51
6.3.1 STANDALONE SOFTWARE 52
6.3.2 INTEGRATED SOFTWARE 53
6.4 SERVICES 54

7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE 55
7.1 INTRODUCTION 56
7.2 ON–PREMISE SOLUTIONS 56
7.3 CLOUD-BASED SOLUTIONS 58

8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 59
8.1 INTRODUCTION 60
8.2 PROVIDERS 60
8.3 PAYERS 61
8.4 PATIENTS 62
8.5 OTHER END USERS 63
?

9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION 65
9.1 INTRODUCTION 66
9.2 HEALTH MANAGEMENT 66
9.3 HOME HEALTH MANAGEMENT 67
9.4 SOCIAL AND BEHAVIORAL MANAGEMENT 68
9.5 FINANCIAL HEALTH MANAGEMENT 69

10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 70
10.1 INTRODUCTION 71
10.1.1 CHRONIC DISEASES 71
10.1.1.1 Diabetes 73
10.1.1.2 Cardiovascular diseases 73
10.1.1.3 Obesity 74
10.1.1.4 Other chronic diseases 75
10.1.2 WOMEN’S HEALTH 75
10.1.3 FITNESS 76
10.1.4 OTHER THERAPEUTIC AREAS 77

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION 78
11.1 INTRODUCTION 79
11.2 NORTH AMERICA 80
11.2.1 US 84
11.2.2 CANADA 91
11.3 EUROPE 95
11.3.1 GERMANY 102
11.3.2 UK 104
11.3.3 FRANCE 107
11.3.4 REST OF EUROPE (ROE) 109
11.4 ASIA PACIFIC 112
11.5 REST OF THE WORLD 118

12 COMPANY PROFILES 122
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 MCKESSON 122
12.2 ALLSCRIPTS 126
12.3 IBM 131
12.4 ATHENAHEALTH 135
12.5 ORION HEALTH 140
12.6 CERNER 144
12.7 GETWELLNETWORK 149
12.8 LINCOR SOLUTIONS 153
12.9 YOURCAREUNIVERSE 156
12.10 WELVU 159
12.11 GET REAL HEALTH 161
12.12 ONEVIEW HEALTHCARE 164

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX 167
13.1 DISCUSSION GUIDE 167
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 172
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 174
13.4 AVAILABLE CUSTOMIZATIONS 175
13.5 RELATED REPORTS 176
13.6 AUTHOR DETAILS 177